|
Lung
cancer antigens defined by serological analysis of testis cDNA
expression libraries.
|
NY-TLU-
Antigen
|
Gene
(UniGene Cluster)
|
Serum
|
NY-TLU-
Antigen
|
Gene
(UniGene Cluster)
|
Serum
|
|
1
|
HOXB6
(Hs.98428)
|
LU413
|
42
|
PHIP
(Hs.9927)
|
LU413
|
|
2
a
|
DR1
(Hs.348418)
|
LU413
|
43
a
|
MPHOSPH1
(Hs.240)
|
LU413
|
|
3
a
|
BRAP
(Hs.122764)
|
LU413
|
44
|
NARF
(Hs.256526)
|
LU413
|
|
4
|
ATF7IP
(Hs.272210)
|
LU413
|
45
|
KNSL7
(Hs.315051)
|
LU413
|
|
5 a
|
KIAA1641 (Hs.458330)
|
LU413
|
46 a
|
S164 (Hs.197184)
|
LU413
|
|
6
|
CDH18 (Hs.57691)
|
LU413
|
47
|
ATP5F1 (Hs.816341)
|
LU413
|
|
7
|
I-4 (Hs.127689)
|
LU413
|
48
|
PELO (Hs.415308)
|
LU413
|
|
8
|
MTO1 (Hs.33979)
|
LU413
|
49
|
UMPK (Hs.458360)
|
LU413
|
|
9 a
|
BCAA (Hs.17428)
|
LU413
|
50
|
IK (Hs.421245)
|
LU413
|
|
10
|
TPM3 (Hs.178468)
|
LU413
|
51
|
CFL1 (Hs.170622)
|
LU413
|
|
11 a
|
HSPCB (Hs.74335)
|
LU413
|
52
|
MAP7 (Hs.254605)
|
LU413
|
|
12
|
HOMER-2B (Hs.93564)
|
LU413
|
53
|
NICE-4 (Hs.8127)
|
LU413
|
|
13 a
|
PABPC4 (Hs.169900)
|
LU413
|
54 a
|
ROCK2 (Hs.58617)
|
LU413
|
|
14
|
HTATSF1 (Hs.204475)
|
LU413
|
55
|
ODF1 (Hs.159274)
|
LU413
|
|
15
|
LOC134218 (Hs.131887)
|
LU413
|
56 a
|
STX4A (Hs.83734)
|
LU413
|
|
16
|
RDBP (Hs.423935)
|
LU413
|
57
|
SLCO6A1 (Hs.388874)
|
LU413
|
|
17
|
RANBP2 (Hs.179825)
|
LU413
|
58
|
RNF38 (Hs.333503)
|
LU413
|
|
18 a
|
WDR11 (Hs.16677)
|
LU413
|
59
|
C1orf33 (Hs.274201)
|
LU413
|
|
19
|
FLJ20542 (Hs.6449)
|
LU413
|
60
|
NKGK (Hs.7036)
|
LU413
|
|
20 a
|
C2orf3 (Hs.184175)
|
LU413
|
61 a
|
PMSCL1 (Hs.91728)
|
LU413
|
|
21
|
DKFZP564 (Hs.42954)
|
LU413
|
62
|
FLJ10980 (Hs.308019)
|
LU413
|
|
22 a
|
TBC1D4 (Hs.173802)
|
LU413
|
63 a
|
ADPRT (Hs.177766)
|
Mix I
|
|
23
|
DKFZP566 (Hs.202306)
|
LU413
|
64
|
NUP50 (Hs.362841)
|
Mix I
|
|
24 a
|
HSPCA (Hs.446579)
|
LU413
|
65 a
|
RBPJK (Hs.347340)
|
Mix I,II,III
|
|
25 a
|
MGC;27017 (Hs.313413)
|
LU413
|
66 a
|
KIAA0373 (Hs.150444)
|
Mix I
|
|
26
|
KIF9 (Hs.373617)
|
LU413
|
67
|
METTL3 (Hs.168799)
|
Mix I
|
|
27
|
COPS6 (Hs.15591)
|
LU413
|
68 a
|
HSF2 (Hs.158195)
|
Mix I
|
|
28
|
HOZFP (Hs.351839)
|
LU413
|
69
|
RTN4 (Hs.436349)
|
Mix II
|
|
29
|
FLJ10890 (Hs.17283)
|
LU413
|
70 a
|
RHAMM (Hs.72550)
|
Mix II
|
|
30
|
RPL31 (Hs.375921)
|
LU413
|
71
|
CCNL1 (Hs.4859)
|
Mix II,III
|
|
31
|
FLJ10980 (Hs.308019)
|
LU413
|
72 a
|
USP16 (Hs.99819)
|
Mix II
|
|
32
|
FLJ20635 (Hs.265018)
|
LU413
|
73
|
EST (Hs.449083)
|
Mix II
|
|
33
|
C20orf4 (Hs.11314)
|
LU413
|
74 a
|
RNASE3L (Hs.438951)
|
Mix II
|
|
34 a
|
MKRN1 (Hs.7838)
|
LU413
|
75
|
NCOA6IP (Hs.179909)
|
Mix II
|
|
35 a
|
U2AFIRS2 (Hs.171909)
|
LU413
|
76
|
THOC2 (Hs.81376)
|
Mix II
|
|
36
|
TDRKH (Hs.144439)
|
LU413
|
77 a
|
HCF-2 (Hs.55601)
|
Mix II,III
|
|
37
|
AKAP3 (Hs.98397)
|
LU413
|
78
|
FLJ10747 (Hs.189782)
|
Mix II
|
|
38
|
Noble (-)
|
LU413
|
79
|
C20orf19 (Hs.436632)
|
Mix III
|
|
39
|
KIAA1317 (Hs.272254)
|
LU413
|
80 a
|
FLJ20274 (Hs.268371)
|
Mix III
|
|
40 a
|
IGHG3 (Hs.300697)
|
LU413
|
81
|
AKP10 (Hs.372446)
|
Mix III
|
|
41 a
|
FLJ20274 (Hs.268371)
|
LU413
|
82 a
|
ORMDL2 (Hs.13144)
|
Mix III
|
a
The antigens were previously identified by SEREX analysis of other
tumor types, as determined by sequence comparison with the SEREX
entries in the Cancer Immunome Database (12).
|
